As reported in the Daily Telegraph, AstraZeneca has recruited leading Scientist Martin Mackay who was previously working at the pharmaceutical company, Pfizer, to lead its research and development operations.
Mackay joined Pfizer in 1995 as head of pharmatherapeutics R&D and was a member of the executive leadership team. He is set to join AstraZeneca on 1st July 2010 and will be taking on the role of president of R&D.
Speaking of Mackay’s arrival to the team, chief executive of AstraZeneca, David Brennan, said the scientist had “impeccable scientific and leadership credentials combined with extensive experience of the pharmaceutical industry”. He added: “I am delighted he is joining us. We have a clear and unambiguous commitment to creating value through innovative biopharmaceuticals with research and development at the heart of our strategy.”
The recruitment of Mackay represents the British drug makers attempt to overhaul its R&D operations and strengthen its drug pipeline.
Looking for a job in the pharmaceutical industry? Click here to search our current pharmaceutical jobs now.